Status:
COMPLETED
Treating Late-Life Generalized Anxiety Disorder (GAD) in Primary Care
Lead Sponsor:
Baylor College of Medicine
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
National Institutes of Health (NIH)
Conditions:
Generalized Anxiety Disorder
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether cognitive behavior therapy (CBT) is effective in the treatment of generalized anxiety disorder (GAD) in adults age 60 and older in a primary care sett...
Detailed Description
Generalized Anxiety Disorder (GAD) is one of the most common anxiety disorders among older adults. Anxiety in older adults is associated with decreased physical activity, poorer self-perceptions of he...
Eligibility Criteria
Inclusion
- Clinical diagnosis of Generalized Anxiety Disorder
Exclusion
- Active suicidal intent
- Current psychosis
- Current bipolar disorder
- Substance abuse within past month
- Cognitive impairment
Key Trial Info
Start Date :
March 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2015
Estimated Enrollment :
148 Patients enrolled
Trial Details
Trial ID
NCT00308724
Start Date
March 1 2004
End Date
April 1 2015
Last Update
March 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Houston Center for Quality of Care and Utilization Studies
Houston, Texas, United States, 77030